Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs

Tuberculosis (TB) is still the number one cause of death due to an infectious disease. Pharmacokinetics and pharmacodynamics of anti-TB drugs are key in the optimization of TB treatment and help to prevent slow response to treatment, acquired drug resistance, and adverse drug effects. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sturkenboom, Marieke G. G., Märtson, Anne-Grete, Svensson, Elin M., Sloan, Derek J., Dooley, Kelly E., van den Elsen, Simone H. J., Denti, Paolo, Peloquin, Charles A., Aarnoutse, Rob E., Alffenaar, Jan-Willem C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935699/
https://www.ncbi.nlm.nih.gov/pubmed/33674941
http://dx.doi.org/10.1007/s40262-021-00997-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935699/
https://www.ncbi.nlm.nih.gov/pubmed/33674941
http://dx.doi.org/10.1007/s40262-021-00997-0

Ejemplares similares